AIM
DGX icon

AIA Investment Management’s Quest Diagnostics DGX Stock Holding History

AIA Investment Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$71K Buy
622
+213
+52% +$25.2K 0.02% 276
2020
Q2 		$47K Buy
409
+190
+87% +$20.2K 0.01% 249
2020
Q1 		$18K Hold
219
– – ﹤0.01% 328
2019
Q4 		$23K Buy
+219
New +$22.8K 0.03% 270

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

AIA Investment Management's DGX Position: Q3 2020 in Review

AIA Investment Management increased its Quest Diagnostics (DGX) stake by 52% in Q3 2020, buying an estimated $25.2K and bringing the position to 622 shares worth $71K. The position accounts for 0.02% of the portfolio, ranked #276.

AIA Investment Management first reported a position in DGX in Q4 2019 and has held it in 4 quarters since. 757 funds tracked by Wall St. Rank hold DGX as of Q3 2020.

  • AIA Investment Management held 622 shares of Quest Diagnostics worth $71K as of Q3 2020.
  • AIA Investment Management bought 213 Quest Diagnostics shares in Q3 2020, an estimated $25.2K.
  • Quest Diagnostics made up 0.02% of AIA Investment Management's portfolio in Q3 2020, its #276 holding.
  • AIA Investment Management first reported a position in Quest Diagnostics in Q4 2019 and has held it in 4 quarters since.
  • 757 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2020.

Based on AIA Investment Management's 13F filing for Q3 2020, filed 16 Nov 2020.